You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
創美藥業(02289.HK)2022年營業收入增加10.06%至41.75億元 末期息0.45元
格隆匯 03-31 21:26

格隆匯3月31日丨創美藥業(02289.HK)發佈公吿,於2022年,公司營業收入為人民幣41.75億元,較2021年增加10.06%。歸屬於母公司股東的淨利潤為人民幣9038萬元,較2021年增加290.36%;每股收益為人民幣0.8369元,董事會建議就截至2022年12月31日止年度派發末期股息每股人民幣0.45元(含税)

淨利潤增長主要由於(i)主營業務收入及毛利的增長;及(ii)佛山物流配送中心已被收儲,相應利潤增加人民幣49.38百萬元。

於2022年12月31日,公司的分銷網絡覆蓋13,396名客户,其中702名為分銷商,8,683名為零售藥店,4,011名為醫院、診所、衞生站及其他。較上年度,客户數量增加771名,其中分銷商增加2名,零售藥店增加702名,醫院、診所、衞生站及其他增加共67名。

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account